66 related articles for article (PubMed ID: 4733167)
1. [The role of anti-aldosterones in the treatment of arterial hypertension].
Corvol P; Ménard J; Milliez P
Rev Prat; 1973 Feb; 23(9):671-2 passim. PubMed ID: 4733167
[No Abstract] [Full Text] [Related]
2. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
[No Abstract] [Full Text] [Related]
3. Primary aldosteronism: the most frequent form of secondary hypertension?
Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
[No Abstract] [Full Text] [Related]
4. [Spironolactones in the treatment of arterial hypertension of different etiologies associated with hyperaldosteronism].
Chikhladze NM
Ter Arkh; 1981; 53(6):74-8. PubMed ID: 7281037
[No Abstract] [Full Text] [Related]
5. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
Gaddam KK; Pratt-Ubunama MN; Calhoun DA
Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of essential arterial hypertension with spironolactone: its value for the screening of primary hyperaldosteronism and prediction of its efficacy].
Fournier A; Lagrue G; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J
Therapeutique; 1973 Feb; 49(2):127-30. PubMed ID: 4732774
[No Abstract] [Full Text] [Related]
9. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
[No Abstract] [Full Text] [Related]
10. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
[No Abstract] [Full Text] [Related]
11. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
12. Conns' syndrome - atypical presentations.
Hari Kumar K; Jha S; Jha R; Modi KD
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):278-81. PubMed ID: 19237819
[TBL] [Abstract][Full Text] [Related]
13. [Sodium-potassium ratio and electrical potential of colon in the screening of hyperaldosteronism (author's transl)].
Pessina AC; Corgnati A; Dal Palù C
G Ital Cardiol; 1974; 4(2):167-72. PubMed ID: 4838120
[No Abstract] [Full Text] [Related]
14. [Electrocardiographic observations in secondary aldosteronism].
Hilmer W
Med Klin; 1972 Jan; 67(4):128-33. PubMed ID: 5060139
[No Abstract] [Full Text] [Related]
15. [Normoaldosterone spironolactone sensitive hypertension].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2006 Apr; 20(118):427-9. PubMed ID: 16886567
[TBL] [Abstract][Full Text] [Related]
16. [Antikaliuretic agents].
Esch I
Internist (Berl); 1971 Aug; 12():Suppl:352-6. PubMed ID: 4937775
[No Abstract] [Full Text] [Related]
17. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
Haschke F; Wimmer M; Parth K
Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
[TBL] [Abstract][Full Text] [Related]
18. Renal calculi in primary hyperaldosteronism.
Kabadi UM
J Postgrad Med; 1995; 41(1):17-8. PubMed ID: 10740696
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
Mantero F; Armanini D; Urbani S
Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
